Author: Mok, Hoyin; Cheng, Xing; Xu, Qi; Zengel, James R; Parhy, Bandita; Zhao, Jackie; Wang, C. Kathy; Jin, Hong
Title: Evaluation of Measles Vaccine Virus as a Vector to Deliver Respiratory Syncytial Virus Fusion Protein or Epstein-Barr Virus Glycoprotein gp350 Document date: 2012_2_16
ID: 3qdjmb2j_18
Snippet: Neutralization assays. Measles virus specific neutralizing antibodies were determined as described previously [34] in 96-well plates using Vero cells. Neutralizing antibody titer is defined as the highest dilution that inhibits 50% CPE. RSV specific neutralizing antibody was determined by the plaque reduction neutralization assay as described previously [35] . The lower limit of detection was 4.3 log 2 and 3.0 log 2 for MV microneutralization and.....
Document: Neutralization assays. Measles virus specific neutralizing antibodies were determined as described previously [34] in 96-well plates using Vero cells. Neutralizing antibody titer is defined as the highest dilution that inhibits 50% CPE. RSV specific neutralizing antibody was determined by the plaque reduction neutralization assay as described previously [35] . The lower limit of detection was 4.3 log 2 and 3.0 log 2 for MV microneutralization and RSV plaque reduction assays, respectively. EBV specific neutralizing antibody titer was determined by the method described by Sashihara et al., [36] .
Search related documents:
Co phrase search for related documents- antibody titer and Neutralization assay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- antibody titer and plaque reduction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- antibody titer and plaque reduction neutralization: 1, 2, 3, 4, 5
- antibody titer and plaque reduction neutralization assay: 1
- antibody titer and RSV plaque reduction: 1
- antibody titer and Vero cell: 1, 2, 3
- detection low limit and low limit: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- Neutralization assay and plaque reduction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- Neutralization assay and plaque reduction neutralization: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- Neutralization assay and plaque reduction neutralization assay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- neutralize antibody and specific neutralize antibody: 1
- plaque reduction and RSV plaque reduction: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date